Clinical life hacks in the treatment of acute bronchitis in post-covid patients with a new generation of phytodrugs BNO1201/1205


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The pandemic of the novel coronavirus disease (COVID-19) has changed the views of practitioners about its consequences for the upper (catarrh) and lower (small bronchi) respiratory tract. COVID-19 has become regarded as a trigger for sudden dysfunction and inflammation («acute bronchitis»), as a trigger for severe exacerbations of bronchial asthma and chronic obstructive pulmonary disease, and as an important prognostic factor for the severity of the disease and premature death of the patient. In most cases, this has led to significant confusion and unreasonable behavior of specialists in the treatment of acute respiratory diseases in post-COVID patients. The purpose of this publication is an objective assessment of the possibilities of drug therapy for acute bronchitis and the reasonable use of modern generation of phytodrugs obtained by scientific engineering (for example, BNO1201/1205) in post-COVID patients, taking into account real clinical practice and current clinical guidelines.

Full Text

Restricted Access

About the authors

Sergey L. Babak

A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia

Email: sergbabak@mail.ru
Dr. med. habil., professor of the Department of phthisiology and pulmonology of the Faculty of general medicine 107150, Moscow, 39/2 Losinoostrovskaya Str

Marina V. Gorbunova

A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia

Email: mgorb@mail.ru
PhD in Medicine, associate professor of the Department of phthisiology and pulmonology of the Faculty of general medicine 107150, Moscow, 39/2 Losinoostrovskaya Str

Ekaterina I. Goruleva

Moscow branch of Medical University «REAVIZ»

Email: 1940858@mail.ru
PhD in Medicine, associate professor of the Department of internal diseases 107150, Moscow, 39/2 Losinoostrovskaya Str

Andrey G. Malyavin

A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia

Email: maliavin@mail.ru
Dr. med. habil., professor, professor of the Department of phthisiology and pulmonology of the Faculty of general medicine 107150, Moscow, 39/2 Losinoostrovskaya Str

References

  1. Jordan R.E., Adab P., Cheng K.K. Covid-19: Risk factors for severe disease and death. BMJ. 2020; 368: m1198. https://dx.doi.org/10.1136/bmj.m1198.
  2. Lombardi C., Gani F., Berti A. et al. Asthma and COVID-19: A dangerous liaison? Asthma Res Pract. 2021; 7(1): 9. https://dx.doi.org/10.1186/s40733-021-00075-z.
  3. Poss-Doering R., Kronsteiner D., Kamradt M. et al. Assessing reduction of antibiotic prescribing for acute, non-complicated infections in primary care in Germany: Multi-step outcome evaluation in the cluster-randomized trial ARena. Antibiotics (Basel). 2021; 10(10): 1151. https://dx.doi.org/10.3390/antibiotics10101151.
  4. Fu M., Wushouer H., Hu L. et al. Outpatient prescribing pattern for acute bronchitis in primary healthcare settings in China. NPJ Prim Care Respir Med. 2021; 31(1): 24. https://dx.doi.org/10.1038/s41533-021-00234-y.
  5. Клинические рекомендации. Острый бронхит у взрослых. Проект. Межрегиональная общественная организация «Российское респираторное общество», общероссийская общественная организация «Российское научное медицинское общество терапевтов», Межрегиональная ассоциация специалистов респираторной медицины (МАСРМ). 2022. Доступ: https://spulmo.ru/upload/kr/OB_2022.pdf (дата обращения - 16.05.2022).
  6. The writings of Benjamin Franklin. Collected and edited with a life and introduction by Albert Henry. London, Macmillan. 1906. Vol. 6. (676): 1773-76.
  7. Hirschmann J.V. Benjamin Franklin and medicine. Ann Intern Med. 2005; 143(11): 830-34. https://dx.doi.org/10.7326/0003-4819-143-11-200512060-00012.
  8. Heikkinen T., Jarvinen A. The common cold. Lancet. 2003; 361(9351): 51-59. https://dx.doi.org/10.1016/S0140-6736(03)12162-9.
  9. Клинические рекомендации. Острые респираторные вирусные инфекции (ОРВИ) у взрослых. Некоммерческое партнерство «Национальное научное общество инфекционистов», общероссийская общественная организация «Российское научное медицинское общество терапевтов». Рубрикатор клинических рекомендаций Минздрава России. 2021. ID: 724. Доступ: https://cr.minzdrav.gov.ru/schema/724_1 (дата обращения - 16.05.2022).
  10. О профилактике ОРВИ и гриппа. Роспотребнадзор. 12.10.2021. Доступ: https://www.rospotrebnadzor.ru/about/info/news/news_details.php?ELEMENT_ID=19240&sphrase_id=4225417 (дата обращения -13.08.2022).
  11. Инфекционные болезни. Национальное руководство. Под ред. акад. РАН Н.Д. Ющука, акад. РАЕН Ю.Я. Венгерова. 2-е изд., переработанное и дополненное. М.: ГЭОТАР-Медиа. 2019; 1004 с. ISBN: 978-5-9704-4912-7.
  12. Jefferson T., Del Mar C.B., Dooley L. et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2020; 11(11): CD006207. https://dx.doi.org/10.1002/14651858.CD006207.pub5.
  13. Чучалин А.Г. Пульмонология. Под ред. А.Г. Чучалина. М.: ГЭОТАР-Медиа. 2020; 768 с. [Chuchalin A.G. Pulmonology. Ed. by Chuchalin A.G. Moscow: GEOTAR-Media. 2020; 768 pp. (In Russ.)]. ISBN: 978-5-9704-5323-0.
  14. Пульмонология. Национальное руководство. Краткое издание. Под ред. акад. РАМН А.Г Чучалина. М.: ГЭОТАР-Медиа. 2018; 800 с. ISBN: 978-5-9704-4814-4.
  15. Irwin R.S., French C.L., Chang A.B., Altman K.W.; CHEST Expert Cough Panel. Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report. Chest. 2018; 153(1): 196-209. https://dx.doi.org/10.1016/j.chest.2017.10.016.
  16. Геппе Н.А. с соавт. Острые инфекции дыхательных путей у детей. Диагностика, лечение, профилактика: клиническое руководство. 2-е изд. обновленное и дополненное. М.: МедКом-Про. 2020; 254 с. ISBN: 978-5-9500978-2-9.
  17. Killeen B.M., Wolfson A.B. Antibiotics for acute bronchitis. Am Fam Physician. 2020; 102(9): Online.
  18. Corbetta L., Arru L.B., Mereu C. et al.Competence and training in interventional pulmonology. Panminerva Med. 2019; 61(3): 203-31. https://dx.doi.org/10.23736/S0031-0808.18.03562-0.
  19. Smith S.M., Fahey T., Smucny J., Becker L.A. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2017; 6(6): CD000245. https://dx.doi.org/10.1002/14651858.CD000245.pub4.
  20. Falzon C.C., Balabanova A. Phytotherapy: An introduction to herbal medicine. Prim Care. 2017; 44(2): 217-27. https://dx.doi.org/10.1016/j.pop.2017.02.001.
  21. Зайцева О.В., Симоновская Х.Ю., Павленко Д.В. В обход необдуманных назначений. Рациональные стратегии борьбы с острыми респираторными инфекциями у детей. М.: Редакция журнала StatusPraesens. 2019; 16 с. ISBN: 978-5-6042694-9-7.
  22. Seibel J., Pergola C., Werz O. et al. Bronchipret® syrup containing thyme and ivy extracts suppresses bronchoalveolar inflammation and goblet cell hyperplasia in experimental bronchoalveolitis. Phytomedicine. 2015; 22(13): 1172-77. https://dx.doi.org/10.1016/j.phymed.2015.09.001.
  23. Seibel J., Kryshen K., Pongracz J.E., Lehner M.D. In vivo and in vitro investigation of anti-inflammatory and mucus-regulatory activities of a fixed combination of thyme and primula extracts. Pulm Pharmacol Ther. 2018; 51: 10-17. https://dx.doi.org/10.1016/j.pupt.2018.04.009.
  24. Seibel J., Pergola C., Werz O. et al. A combination of thyme and primula dry extracts possesses antitussive activity and inhibits leukotriene formation. Eur Respir J. 2013; 42(Suppl 57): 743. Print ISSN: 0903-1936; Online ISSN: 1399-3003. Published online July 25, 2014.
  25. Giembycz M.A., Newton R. Beyond the dogma: Novel beta2-adrenoceptor signalling in the airways. Eur Respir J. 2006; 27(6): 1286306. https://dx.doi.org/10.1183/09031936.06.00112605.
  26. Nach Haberlein H. ein Beitrag zum Wirkmechanismus von Efeu, PZ 150 Jahrgang, 2005.
  27. Bussmann H., Schulte-Michels J., Bingel M. et al. A comparative study on the influence of an ivy preparation and an ivy/thyme combination on the ß2-adrenergic signal transduction. Heliyon. 2020; 6(5): e03960. https://dx.doi.org/10.1016/j.heliyon.2020.e03960.
  28. Michaleas S.N., Pantos C., Chatzipanagiotou S. et al. Theophrastus Bombastus von Hohenheim: Theological reformer, philosopher and physician. J Relig Health. 2021; 60(6): 3907-14. https://dx.doi.org/10.1007/s10943-021-01265-y.
  29. Muller M, Sewald K, Braun A. Anti-inflammatory efficacy of the herbal medicinal product Bronchipret® tablets in murine respiratory syncytial virus lung infection. Keystone Symposia: Keystone 2014.
  30. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Assessment report on Thymus vulgaris L. and Thymus zygis L., herba and Primula veris L. and Primula elatior (L.) Hill, radix. 5 April 2016. URL: https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-thymus-vulgaris-l-thymus-zygis-l-herba-primula-veris-l-primula-elatior-l_en.pdf (date of access - 13.08.2022).
  31. Sierocinski E., Holzinger F., Chenot J.F. Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review. Eur J Clin Pharmacol. 2021; 77(8): 1113-22. https://dx.doi.org/10.1007/s00228-021-03090-4.
  32. Kardos P., Dinh Q.T., Fuchs K.H. et al. [Guidelines of the German Respiratory Society for diagnosis and treatment of adults suffering from acute, subacute and chronic cough. Pneumologie. 2019; 73(3): 143-80 (In German)]. https://dx.doi.org/10.1055/a-0808-7409.
  33. DEGAM-Leitlinie S3: Akuter und chronischer Husten, 2021. URL: https://www.awmf.org/uploads/tx_szleitlinien/053-013l_S3_akuter-und-chronischer-Husten_2022-01.pdf (date of access - 13.08.2022) (In German)].
  34. Клинические рекомендации. Бронхит. Союз педиатров России, Межрегиональная ассоциация по клинической микробиологии и антимикробной, химиотерапии, Российское респираторное общество. Рубрикатор клинических рекомендаций Минздрава России. 2021. ID: 381. Доступ: https://cr.minzdrav.gov.ru/schema/381_2 (дата обращения - 16.05.2022).

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2022 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies